Taiwan - Delayed Quote TWD

Apex Biotechnology Corp. (1733.TW)

Compare
29.95
0.00
(0.00%)
At close: 1:30:29 PM GMT+8
Currency in TWD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
1,808,443.00
1,676,537.00
2,244,176.00
2,131,656.00
2,005,337.00
Cost of Revenue
1,301,510.00
1,145,421.00
1,667,337.00
1,560,144.00
1,553,113.00
Gross Profit
506,933.00
531,116.00
576,839.00
571,512.00
452,224.00
Operating Expense
386,362.00
387,583.00
400,279.00
370,058.00
349,258.00
Operating Income
120,571.00
143,533.00
176,560.00
201,454.00
102,966.00
Net Non Operating Interest Income Expense
-1,890.00
-2,606.00
-4,821.00
-12,116.00
-7,886.00
Pretax Income
120,725.00
140,962.00
199,575.00
184,936.00
110,615.00
Tax Provision
16,073.00
25,248.00
18,124.00
-17,353.00
15,986.00
Net Income Common Stockholders
104,671.00
115,783.00
181,785.00
202,224.00
94,795.00
Diluted NI Available to Com Stockholders
104,671.00
115,783.00
181,785.00
202,224.00
94,795.00
Basic EPS
1.05
1.16
1.82
2.03
0.95
Diluted EPS
1.04
1.15
1.81
1.93
0.87
Basic Average Shares
99,821.82
99,950.00
99,950.00
99,732.00
99,541.00
Diluted Average Shares
100,288.72
100,326.00
100,671.00
105,637.00
113,020.00
Total Expenses
1,687,872.00
1,533,004.00
2,067,616.00
1,930,202.00
1,902,371.00
Net Income from Continuing & Discontinued Operation
104,671.00
115,783.00
181,785.00
202,224.00
94,795.00
Normalized Income
106,012.90
117,274.55
181,785.00
199,428.00
94,485.32
Interest Income
1,784.00
1,782.00
577.00
414.00
2,389.00
Interest Expense
3,674.00
4,388.00
5,398.00
12,530.00
10,275.00
Net Interest Income
-1,890.00
-2,606.00
-4,821.00
-12,116.00
-7,886.00
EBIT
124,399.00
145,350.00
204,973.00
197,466.00
120,890.00
EBITDA
191,283.00
221,060.00
299,073.00
293,141.00
226,088.00
Reconciled Cost of Revenue
1,301,510.00
1,145,421.00
1,667,337.00
1,560,144.00
1,553,113.00
Reconciled Depreciation
66,884.00
75,710.00
94,100.00
95,675.00
105,198.00
Net Income from Continuing Operation Net Minority Interest
104,671.00
115,783.00
181,785.00
202,224.00
94,795.00
Total Unusual Items Excluding Goodwill
-1,548.00
-1,817.00
--
3,495.00
362.00
Total Unusual Items
-1,548.00
-1,817.00
--
3,495.00
362.00
Normalized EBITDA
192,831.00
222,877.00
299,073.00
289,646.00
225,726.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-206.10
-325.45
--
699.00
52.32
12/31/2020 - 6/14/2000

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

1734.TW Sinphar Pharmaceutical Co.,Ltd.
30.75
+0.33%
 
1762.TW Chunghwa Chemical Synthesis & Biotech Co., Ltd.
33.20
+0.30%
 
3164.TW GenMont Biotech Incorporation
19.45
+1.04%
 
4133.TW Abnova (Taiwan) Corporation
29.80
-1.16%
 
1760.TW Panion & Bf Biotech Inc.
82.70
+1.10%
 
6885.TW BRIM Biotechnology, Inc.
28.90
-2.03%
 
3205.TWO Sagittarius Life Science Corp
33.95
-1.59%
 
6838.TW Formosa Pharmaceuticals, Inc.
34.00
-0.73%
 
3118.TWO Level Biotechnology Inc.
32.35
-0.15%
 
4167.TWO Savior Lifetec Corporation
19.75
-0.25%